2m 2m 2m 2m 2m 2m 2m
ENTRADA THERAPET (TRDA)
NASDAQ
$6.79-$0.010 (-0.15%)
Price as of Sep 11, 2026 7:30 PM EDT- $264.8MMarket Cap
- 28.79%1-Year Change
- BiotechnologyIndustry
ENTRADA THERAPET (TRDA)
$6.79-$0.010 (-0.15%)
TRDA | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $6.80 | ||
Change | +$0.38 (+5.92%) | ||
Open | $6.49 | ||
High | $6.81 | ||
Low | $6.29 | ||
Previous Close | $6.42 | ||
Volume | 291,808 | ||
30-Day Average Volume | 276,066 | ||
1-Week Change | -4.63% | ||
1-Month Change | -3.41% | ||
1-Year Change | 28.79% | ||
3-Year Change | -53.74% | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 38.9M | ||
Total Assets | $298.9M | ||
Market Cap | $264.8M | ||
Enterprise Value | $165.5M | ||
Period: QTR TTM FY | |||
Revenue | $898,000.00 | ||
Net Income | -$42.8M | ||
Free Cash Flow | -$32.5M | ||
EBIT | -$42.7M | ||
EBITDA | -$41.9M | ||
Net Working Capital | $211.3M | ||
EPS | -$1.01 | ||
Enterprise Value/EBITDA | -4 | ||
Enterprise Value/Revenue | 184 | ||
P/B | 1 | ||
P/E | -7 | ||
PEG | 1 | ||
Price/Free Cash Flow | -8 | ||
Price/Operating Cash Flow | -8 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue